Singapore - Breathtec Biomedical is pleased to announce that further to its press release of August 2, 2018, it ha...
Singapore - The FDA has released new guidance documents aimed at advancing development of generic versio...
Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal ...
Bionure Farma, a spin-off from the Hospital Clinic of Barcelona (Spain) specialized in neuroprotection has announced the...
Roche recently announced that the US Food and Drug Administration (FDA) has approved Hemlibra (emicizumab-kxwh) fo...
Singapore - Irvine, CA-based Axonics Modulation Technologies (AXNX) has filed a prospectus for an $8...
Singapore - Pall Corporation, a global leader in filtration, separation and purification, has progressed a strategic par...
Drug delivery systems provider Aptar Pharma has introduced a new portable, drug delivery device called PureHale to help ...
Singapore - Breakthrough innovation specialists Cambridge Consultants and CATALOG Technologies, a company which dev...
Exscientia, announced the appointment of Mr Georgy Egorov as Chief Financial Officer (CFO) effective immediately. ...
Singapore - Scythian Biosciences announced Brady Cobb, a leading voice in the medical cannabis industry, has been appoin...
Singapore - Johnson & Johnson has dissolved its four-year-old partnership with Geron for cancer drug imetelstat...
Singapore - Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dosevac...
Chemists, chromatographers and molecular biologists can now benefit from the first-ever line of vacuum concentra...
Singapore - Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has appro...
From October 1, 2018, until January 15, 2019, young researchers not older than 35 years, with an advanced degree, who ar...
Ahead of the inaugural edition of bioLIVE, the bioprocessing and manufacturing event opening October (9-11) in Madrid, C...
Pharma giant GSK and Aeras reported that GSK’s candidate vaccine significantly reduced the incidence of pulmonary ...
